Sirolimus Solution
Product Images NDC 72205-099

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Sirolimus (NDC 72205-099). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sirolimus-carton-label (Sirolimus Carton Label)

Sirolimus-carton-label (Sirolimus Carton Label)
This is a description of a medication named Sirolimus Oral Solution. The medicine comes in a bottle of 60mL that contains 1 mg of sirolimus per mL. The solution is for oral use only and should be stored refrigerated at a temperature between 2° to 8°C. The pharmacist should dispense the accompanying Medication Guide to each patient. It is manufactured by MSN Pharmaceuticals Inc. and distributed by Novadoz Pharmaceuticals LLC. The dosage and usage instructions are provided in the accompanying prescribing information. The product is available with a prescription (Rx Only) and the NDC number is 72205-099-78.*
FDA Label Image

Sirolimus-container-label (Sirolimus Container Label)

Sirolimus-container-label (Sirolimus Container Label)
Sirolimus Oral Solution is a medication that can be taken orally. Pharmacies should dispense the accompanying Medication Guide to each patient. Each mL of this drug contains 1 mg sirolimus along with 1.5%-2.5% ethanol, propylene glycol, phosphatidylcholine derived from soy lecithin and other components, and polysorbate 80. The recommended dosage and usage information can be found in the accompanying prescribing information. This drug should be refrigerated at 2° to 8°C (36° to 46°F), stored away from light and used within one month of opening. Keep out of reach of children. The manufacturer is MSN Pharmaceuticals Inc. and it is distributed by Novadoz Pharmaceuticals LLC. The expiration date on this medication is 02/2023.*
FDA Label Image

Sirolimus-fig-1 (Sirolimus Fig 1)

FDA Label Image

Sirolimus-instruction-fig-1 (Sirolimus Instruction Fig 1)

FDA Label Image

Sirolimus-instruction-fig-2 (Sirolimus Instruction Fig 2)

FDA Label Image

Sirolimus-instruction-fig-3 (Sirolimus Instruction Fig 3)

FDA Label Image

Sirolimus-instruction-fig-4 (Sirolimus Instruction Fig 4)

FDA Label Image

Sirolimus-instruction-fig-5 (Sirolimus Instruction Fig 5)

FDA Label Image

Sirolimus-instructions-fig-6 (Sirolimus Instruction Fig 6)

FDA Label Image

Sirolimus-instruction-fig-7 (Sirolimus Instruction Fig 7)

FDA Label Image

Sirolimus-instruction-fig (Sirolimus Instruction Fig)

FDA Label Image

Sirolimus-kit-carton-label (Sirolimus Kit Carton Label)

Sirolimus-kit-carton-label (Sirolimus Kit Carton Label)
This text provides instructions for using Sirolimus oral solution for patients in the form of a patient kit. The kit includes a 60 mL bottle of Sirolimus oral solution, oral syringes, and a carrying case, among other items. The instructions cover how to withdraw the prescribed dosage of the solution using the included oral syringes and store the remaining solution. Additionally, the instructions detail how to take the dose of the Sirolimus Oral Solution using a glass or plastic cup and water or orange juice, and never to use it with apple juice or grapefruit juice. The storage temperature for the solution is also detailed.*
FDA Label Image

Sirolimus-structure (Sirolimus Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.